Elizabeth Lyden

Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative Groups

Odile Oberlin, Annie Rey, Elizabeth Lyden et al. · Journal of Clinical Oncology · 2008 · 473 citations · Full text

Medicine, Oncology, Surgery +14

Prognostic Factors and Clinical Outcomes in Children and Adolescents With Metastatic Rhabdomyosarcoma—A Report From the Intergroup Rhabdomyosarcoma Study IV

John C. Breneman, Elizabeth Lyden, Alberto S. Pappo et al. · Journal of Clinical Oncology · 2002 · 470 citations

Medicine, Oncology, Pediatrics +17

Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group

Brenda J. Weigel, Elizabeth Lyden, James R. Anderson et al. · Journal of Clinical Oncology · 2015 · 220 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Two Consecutive Phase II Window Trials of Irinotecan Alone or in Combination With Vincristine for the Treatment of Metastatic Rhabdomyosarcoma: The Children's Oncology Group

Alberto S. Pappo, Elizabeth Lyden, P P Breitfeld et al. · Journal of Clinical Oncology · 2007 · 202 citations · Full text

Medicine, Oncology, Pharmacology +16

Marital Status and Survival in Pancreatic Cancer Patients: A SEER Based Analysis

Michael J. Baine, Freshta Sahak, Chi Lin et al. · PLoS ONE · 2011 · 180 citations · Full text

Medicine, Oncology, Surgery +17